back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2026-01-24 12:35 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Ann Rothwell (Spouse) (Indirect Ownership)
|
Common Shares
54 - Exercise of warrants
|
$30,000
+10,000 vol $3.00 each |
199,810 | |
| Filed 2026-01-24 12:30 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
54 - Exercise of warrants
|
$150,000
+50,000 vol $3.00 each |
509,690 | |
| Filed 2026-01-24 12:28 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Held Jointly with Spouse (Control or Direction)
|
Common Shares
54 - Exercise of warrants
|
$132,000
+44,000 vol $3.00 each |
294,500 | |
| Filed 2026-01-24 12:23 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Ann Rothwell (Spouse) (Indirect Ownership)
|
Warrants
54 - Exercise of warrants
|
$-30,000
-10,000 vol $3.00 each |
0 | |
| Filed 2026-01-24 12:22 Tx date 2026-01-23 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Held Jointly with Spouse (Control or Direction)
|
Warrants
54 - Exercise of warrants
|
$-282,000
-94,000 vol $3.00 each |
0 | |
| Filed 2026-01-24 12:17 Tx date 2026-01-21 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Ann Rothwell (Spouse) (Indirect Ownership)
|
Warrants
10 - Acquisition or disposition in the public market
|
$-224,000
-20,000 vol $11.20 each |
10,000 | |
| Filed 2026-01-24 12:16 Tx date 2026-01-21 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Held Jointly with Spouse (Control or Direction)
|
Warrants
10 - Acquisition or disposition in the public market
|
$-242,200
-21,625 vol $11.20 each |
94,000 | |
| Filed 2026-01-24 12:15 Tx date 2026-01-21 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
10 - Acquisition or disposition in the public market
|
$-1,213,800
-108,375 vol $11.20 each |
0 | |
| Filed 2025-12-22 13:09 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$5,178,000
+600,000 vol $8.63 each |
600,000 | |
| Filed 2025-12-22 13:07 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$401,295
+46,500 vol $8.63 each |
646,500 | |
| Filed 2025-12-22 13:07 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$198,490
+23,000 vol $8.63 each |
669,500 | |
| Filed 2025-12-19 21:29 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$198,490
+23,000 vol $8.63 each |
||
| Filed 2025-12-19 21:29 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$401,295
+46,500 vol $8.63 each |
||
| Filed 2025-12-19 21:27 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$5,178,000
+600,000 vol $8.63 each |
||
| Filed 2025-12-19 21:31 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$1,348,437
+156,250 vol $8.63 each |
446,250 | |
| Filed 2025-12-19 21:30 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$647,250
+75,000 vol $8.63 each |
290,000 | |
| Filed 2025-12-19 21:29 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$198,490
+23,000 vol $8.63 each |
669,500 | |
| Filed 2025-12-19 21:29 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$401,295
+46,500 vol $8.63 each |
646,500 | |
| Filed 2025-12-19 21:27 Tx date 2025-12-15 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
56 - Grant of rights
|
$5,178,000
+600,000 vol $8.63 each |
600,000 | |
| Filed 2025-12-19 21:23 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Rights Restricted Stock Unit
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2025-02-21 20:53 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Ann Rothwell (Spouse) (Indirect Ownership)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
30,000 | ||
| Filed 2025-02-21 20:52 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Held Jointly with Spouse (Control or Direction)
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
115,625 | ||
| Filed 2025-02-21 20:52 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
108,375 | ||
| Filed 2025-02-21 20:34 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
215,000 | ||
| Filed 2025-02-21 20:27 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Temperance Capital (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2025-02-21 20:26 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Held Jointly with Spouse (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
250,500 | ||
| Filed 2025-02-21 20:25 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Holder: Ann Rothwell (Spouse) (Indirect Ownership)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
189,810 | ||
| Filed 2025-02-21 20:22 Tx date 2025-02-17 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
459,690 | ||
| Filed 2021-03-16 19:03 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Holder: held jointly with spouse (Control or Direction)
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-03-16 19:01 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 17:48 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2021-03-15 17:48 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
50,000 | ||
| Filed 2021-03-15 17:22 Tx date 2021-03-09 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
15 - Acquisition or disposition under a prospectus
|
$3,100,000
+387,500 vol $8.00 each |
487,500 | |
| Filed 2021-03-15 17:20 Tx date 2021-03-03 |
$EPRX
Eupraxia Pharmaceuticals Inc. |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
100,000 | ||
| Filed 2018-06-12 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2018-06-12 Tx date 2018-06-05 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+125,000 vol |
||
| Filed 2018-06-12 Tx date 2018-06-05 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
11 - Acquisition or disposition carried out privately
|
+125,000 vol |
||
| Filed 2018-06-12 Tx date 2018-06-05 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
51 - Exercise of options
|
-125,000 vol |
0 | |
| Filed 2018-06-12 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
125,000 | ||
| Filed 2018-06-12 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2018-06-12 Tx date 2018-06-05 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
51 - Exercise of options
|
$44,375
+125,000 vol $0.355 each |
250,000 | |
| Filed 2018-06-12 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
|||
| Filed 2017-09-22 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
500,000 | ||
| Filed 2017-08-16 Tx date 2017-06-23 |
$PROS
ProSmart Enterprises Inc. (formerly, Sora Capital Corp.) |
Rothwell, Alexander John
4 - Director of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
500,000 |